Factors associated with decisions to step down asthma medications

J Allergy Clin Immunol Pract. 2013 May-Jun;1(3):312-4. doi: 10.1016/j.jaip.2013.02.005. Epub 2013 Apr 9.

Authors

Matthew A Rank¹, Jeanette Y Ziegenfuss², Kunal M Shah³, Sarah M Jenkins⁴, Kandace A Lackore⁵, David T Eton⁵, Nilay D Shah⁵

Affiliations

¹ Division of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Scottsdale, Ariz. Electronic address: rank.matthew@mayo.edu.
² HealthPartners, Bloomington, Minn.
³ Division of Allergy and Immunology, Mayo Clinic Health System, Mankato, Minn.
⁴ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minn.
⁵ Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minn.

PMID: 24565495
DOI: 10.1016/j.jaip.2013.02.005

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Age Factors
Asthma* / diagnosis
Asthma* / physiopathology
Child
Child, Preschool
Chronic Disease
Contraindications
Decision Making*
Drug Therapy* / economics
Drug Therapy* / standards
Emergency Medical Services
Female
Health Care Surveys
Hospitalization
Humans
Male
Middle Aged
Sex Factors
Time Factors
Young Adult